Cresco Labs Inc.
CL
CNSX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -5.73% | -4.53% | -6.43% | -4.61% | -5.51% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -5.73% | -4.53% | -6.43% | -4.61% | -5.51% |
| Cost of Revenue | -0.23% | -10.91% | -19.43% | -14.99% | -17.68% |
| Gross Profit | -11.18% | 2.34% | 11.11% | 9.07% | 10.71% |
| SG&A Expenses | 3.45% | -7.35% | -19.83% | -26.11% | -33.19% |
| Depreciation & Amortization | -45.31% | -4.04% | 19.42% | 26.89% | 65.89% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -1.86% | -9.32% | -18.65% | -18.43% | -21.42% |
| Operating Income | -26.17% | 31.87% | 190.06% | 629.09% | 1,472.51% |
| Income Before Tax | -76.17% | 109.50% | -38.66% | 244.94% | 108.17% |
| Income Tax Expenses | -67.09% | 430.94% | -26.54% | 7.10% | -66.54% |
| Earnings from Continuing Operations | -90.98% | 93.22% | -17.75% | 92.61% | 102.70% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -115.45% | -33.85% | -145.50% | -278.19% | -111.58% |
| Net Income | -265.92% | 90.88% | -48.72% | 80.07% | 101.63% |
| EBIT | -26.17% | 31.87% | 190.06% | 629.09% | 1,472.51% |
| EBITDA | -28.28% | 17.72% | 88.71% | 164.15% | 303.59% |
| EPS Basic | -261.54% | 91.15% | -35.19% | 82.22% | 101.46% |
| Normalized Basic EPS | -147.86% | 23.08% | -1,600.00% | 200.53% | -57.96% |
| EPS Diluted | -261.54% | 91.15% | -35.19% | 82.22% | 101.46% |
| Normalized Diluted EPS | -147.86% | 23.08% | -1,600.00% | 200.53% | -57.96% |
| Average Basic Shares Outstanding | 2.60% | 2.93% | 9.98% | 12.12% | 12.15% |
| Average Diluted Shares Outstanding | 2.60% | 2.93% | 9.98% | 12.12% | 12.15% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |